Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Hematologic Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 12 Lung Neoplasms 9 Colorectal Neoplasms 8 Prostatic Neoplasms 7 Breast Neoplasms 7 Stomach Neoplasms 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Pancreatic cancer, adult 2 Ovarian Neoplasms 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Wilms Tumor 1 Venous Thromboembolism 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Smoking Cessation 1 Skin Neoplasms 1 Sezary Syndrome 1 Retroviridae Infections 1

Interventions

enzalutamide 7 Prednisone 7 cabazitaxel 6 Radiosurgery 5 Docetaxel 5 Androgen Antagonists 4 Abiraterone Acetate 4 XRP6258 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 pembrolizumab 1 olaparib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 darolutamide 1 apalutamide 1 Zuclomiphene 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 LY3023414 1 Injections 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03223727 2023-04-18

ROTOR

The Netherlands Cancer Institute

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡